Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in African American Veterans With Non-Diabetic Chronic Kidney Disease
NCT06110130Phase 4Recruiting
- Sponsor
- Department of Veterans Affairs Medical Centers
- Start
- Feb 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in chronic kidney disease (CKD), sponsored by Department of Veterans Affairs Medical Centers. Started Feb 2024; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT06110130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06110130.